The Pharmaceuticals sector of Canada witnessed 4 Equity Offering deals in July 2022, for an aggregate deal value of $203.5 million. This represents a decrease of 87.1% in terms of value and a decrease of 83.0% in terms of volume, year over year.
A total of 67 Equity Offering deals were recorded over the last twelve months (LTM) for an aggregate deal value of $1,747.7 million. In the LTM period, October 2021, turned out to be the most prolific in terms of deal size, with a total deal value of $38.5 million and a deal volume of 1 during that month. On the other hand, the month of March 2022, was the most prolific in terms of deal volume, recording a total of 3 deals with a total deal value of $681,625.1 million during that month.
On an average, over the LTM period, 5 deals were done with an average deal size of $145.6 million.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward